| Pack Size | Purity | List Price | Your Price | Stock | Quantity |
|---|---|---|---|---|---|
| 250 mg | 99% | Verify captcha to see price | In stock | ||
| 1 g | 99% | Verify captcha to see price | In stock | ||
| 5 g | 99% | Verify captcha to see price | Inquiry |
Product Name |
(R)-3-(4-Hydroxyphenyl)chroman-7-ol |
|---|---|
CAS No. |
221054-79-1 |
Synonym |
STK801893 | CS-8182 | R-Equol | AKOS004120071 | BBL026747 | DTXSID101318590 | EQUOL (R)-FORM [MI] | EX-A1353 | MFCD09025608 | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol | 2V8RAP1HXA | (3R)-3-(4-HYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL | I |
IUPAC Name |
(R)-3-(4-hydroxyphenyl)chroman-7-ol |
MDL No. |
- |
Molecular Formula |
C15H14O3 |
Molecular Weight |
242.27 |
SMILES |
OC1=CC2=C(C=C1)C[C@H](C3=CC=C(O)C=C3)*** |
Canonical SMILES |
OC1C=CC2C[C@@H](COC=2C=1)C1C=CC(O)=C*** |
InChI |
InChI=1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m0/s1 |
Useage |
(R)-Equol is used as an agonist of estrogen receptors ERα and ERβ; it exhibits inhibitory effects on the invasive capacity of MDA-MB-231 breast cancer cells; it down-regulates matrix metalloproteinase-2 (MMP-2) expression; it reduces tumor number, tumor weight, and tumor incidence in vivo; and it significantly increases tumor latency in animal models. |
InChI Key |
ADFCQWZHKCXPAJ-LBPRGKRZSA-N |
PubChem CID |
6950272 |
Pictogram |
|
|---|---|
Signal Word |
Warning |
Hazard Statement(s) |
H302-
H312-
H332-
|
Precautionary Statement(s) |
P261-
P264-
P270-
P271-
P280-
P301+P312-
P302+P352-
P304+P340-
P330-
P501-
|
|
|
Comment |
|---|
